ReP USP - Resultado da busca

Artigo de periodico
Optimizing therapeutic drug monitoring in pregnant women: a critical literature review (2023)
Moreira, Fernanda de Lima ; Benzi, Jhohann Richard de Lima ; Pinto, Leonardo; Thomaz, Matheus de Lucca; Duarte, Geraldo ; Lanchote, Vera Lucia
Source: Therapeutic Drug Monitoring. Unidades: FMRP, FCFRP
Subjects: ANTIMALÁRICOS, GRAVIDEZ, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Fernanda de Lima et al. Optimizing therapeutic drug monitoring in pregnant women: a critical literature review. Therapeutic Drug Monitoring, v. 45, n. 2, p. 159-172, 2023Tradução . . Disponível em: https://doi.org/10.1097/FTD.0000000000001039. Acesso em: 06 nov. 2024.
APA
Moreira, F. de L., Benzi, J. R. de L., Pinto, L., Thomaz, M. de L., Duarte, G., & Lanchote, V. L. (2023). Optimizing therapeutic drug monitoring in pregnant women: a critical literature review. Therapeutic Drug Monitoring, 45( 2), 159-172. doi:10.1097/FTD.0000000000001039
NLM
Moreira F de L, Benzi JR de L, Pinto L, Thomaz M de L, Duarte G, Lanchote VL. Optimizing therapeutic drug monitoring in pregnant women: a critical literature review [Internet]. Therapeutic Drug Monitoring. 2023 ; 45( 2): 159-172.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1097/FTD.0000000000001039
Vancouver
Moreira F de L, Benzi JR de L, Pinto L, Thomaz M de L, Duarte G, Lanchote VL. Optimizing therapeutic drug monitoring in pregnant women: a critical literature review [Internet]. Therapeutic Drug Monitoring. 2023 ; 45( 2): 159-172.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1097/FTD.0000000000001039
Artigo de periodico
P-Glycoprotein and organic anion transporter polypeptide 1B/breast cancer resistance protein drug transporter activity in pregnant women living with HIV (2023)
Moreira, Fernanda de Lima; Melli, Patrícia Pereira dos Santos; Marques, Maria Paula ; Rocha, Adriana; Nardotto, Glauco Henrique Balthazar ; Duarte, Geraldo; Lanchote, Vera Lucia
Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: NEOPLASIAS MAMÁRIAS, INFECÇÕES POR HIV, INTERAÇÃO DE MEDICAMENTOS, GRAVIDEZ, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Fernanda de Lima et al. P-Glycoprotein and organic anion transporter polypeptide 1B/breast cancer resistance protein drug transporter activity in pregnant women living with HIV. The Journal of Clinical Pharmacology, v. 63, n. 2, p. 219-227, 2023Tradução . . Disponível em: https://doi.org/10.1002/jcph.2152. Acesso em: 06 nov. 2024.
APA
Moreira, F. de L., Melli, P. P. dos S., Marques, M. P., Rocha, A., Nardotto, G. H. B., Duarte, G., & Lanchote, V. L. (2023). P-Glycoprotein and organic anion transporter polypeptide 1B/breast cancer resistance protein drug transporter activity in pregnant women living with HIV. The Journal of Clinical Pharmacology, 63( 2), 219-227. doi:10.1002/jcph.2152
NLM
Moreira F de L, Melli PP dos S, Marques MP, Rocha A, Nardotto GHB, Duarte G, Lanchote VL. P-Glycoprotein and organic anion transporter polypeptide 1B/breast cancer resistance protein drug transporter activity in pregnant women living with HIV [Internet]. The Journal of Clinical Pharmacology. 2023 ; 63( 2): 219-227.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/jcph.2152
Vancouver
Moreira F de L, Melli PP dos S, Marques MP, Rocha A, Nardotto GHB, Duarte G, Lanchote VL. P-Glycoprotein and organic anion transporter polypeptide 1B/breast cancer resistance protein drug transporter activity in pregnant women living with HIV [Internet]. The Journal of Clinical Pharmacology. 2023 ; 63( 2): 219-227.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/jcph.2152
Artigo de periodico
Enhanced elimination of betamethasone in dichorionic twin pregnancies (2022)
Rodrigues, Grazielle de Fátima Pinto ; Benzi, Jhohann Richard de Lima ; Matos, Luísa Helena de Castro; Freitas, Stella Felippe de; Marques, Maria Paula ; Cavalli, Ricardo de Carvalho; Moisés, Elaine Christine Dantas ; Duarte, Geraldo; Lanchote, Vera Lucia ; Marcolin, Alessandra Cristina
Source: British Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: GRAVIDEZ, FARMACOCINÉTICA, PLACENTA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Grazielle de Fátima Pinto et al. Enhanced elimination of betamethasone in dichorionic twin pregnancies. British Journal of Clinical Pharmacology, v. 88, n. 4, p. 1897-1903, 2022Tradução . . Disponível em: https://doi.org/10.1111/bcp.15111. Acesso em: 06 nov. 2024.
APA
Rodrigues, G. de F. P., Benzi, J. R. de L., Matos, L. H. de C., Freitas, S. F. de, Marques, M. P., Cavalli, R. de C., et al. (2022). Enhanced elimination of betamethasone in dichorionic twin pregnancies. British Journal of Clinical Pharmacology, 88( 4), 1897-1903. doi:10.1111/bcp.15111
NLM
Rodrigues G de FP, Benzi JR de L, Matos LH de C, Freitas SF de, Marques MP, Cavalli R de C, Moisés ECD, Duarte G, Lanchote VL, Marcolin AC. Enhanced elimination of betamethasone in dichorionic twin pregnancies [Internet]. British Journal of Clinical Pharmacology. 2022 ; 88( 4): 1897-1903.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1111/bcp.15111
Vancouver
Rodrigues G de FP, Benzi JR de L, Matos LH de C, Freitas SF de, Marques MP, Cavalli R de C, Moisés ECD, Duarte G, Lanchote VL, Marcolin AC. Enhanced elimination of betamethasone in dichorionic twin pregnancies [Internet]. British Journal of Clinical Pharmacology. 2022 ; 88( 4): 1897-1903.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1111/bcp.15111
Artigo de periodico
Chiral transplacental pharmacokinetics of fexofenadine: impact of P-Glycoprotein inhibitor fluoxetine using the human placental perfusion model (2021)
Pinto, Leonardo Santos Ribeiro; Bapat, Priya; Moreira, Fernanda de Lima; Lubetsky, Angelika; Cavalli, Ricardo de Carvalho; Berger, Howard; Lanchote, Vera Lucia ; Koren, Gideon
Source: Pharmaceutical Research. Unidades: FCFRP, FMRP
Subjects: ANTAGONISTAS, FARMACOTERAPIA, ANTIDEPRESSIVOS, PLACENTA, COMPLICAÇÕES NA GRAVIDEZ, ANTI-HISTAMÍNICOS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Leonardo Santos Ribeiro et al. Chiral transplacental pharmacokinetics of fexofenadine: impact of P-Glycoprotein inhibitor fluoxetine using the human placental perfusion model. Pharmaceutical Research, v. 38, n. 4, p. 647-655, 2021Tradução . . Disponível em: https://doi.org/10.1007/s11095-021-03035-7. Acesso em: 06 nov. 2024.
APA
Pinto, L. S. R., Bapat, P., Moreira, F. de L., Lubetsky, A., Cavalli, R. de C., Berger, H., et al. (2021). Chiral transplacental pharmacokinetics of fexofenadine: impact of P-Glycoprotein inhibitor fluoxetine using the human placental perfusion model. Pharmaceutical Research, 38( 4), 647-655. doi:10.1007/s11095-021-03035-7
NLM
Pinto LSR, Bapat P, Moreira F de L, Lubetsky A, Cavalli R de C, Berger H, Lanchote VL, Koren G. Chiral transplacental pharmacokinetics of fexofenadine: impact of P-Glycoprotein inhibitor fluoxetine using the human placental perfusion model [Internet]. Pharmaceutical Research. 2021 ; 38( 4): 647-655.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s11095-021-03035-7
Vancouver
Pinto LSR, Bapat P, Moreira F de L, Lubetsky A, Cavalli R de C, Berger H, Lanchote VL, Koren G. Chiral transplacental pharmacokinetics of fexofenadine: impact of P-Glycoprotein inhibitor fluoxetine using the human placental perfusion model [Internet]. Pharmaceutical Research. 2021 ; 38( 4): 647-655.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s11095-021-03035-7
Artigo de periodico
Determination of misoprostol acid in plasma samples by UPLC–MS/MS with application in a maternal-fetal pharmacokinetic study following a low misoprostol dose vaginally to induce labor (2021)
Filgueira, Gabriela Campos de Oliveira; Rodrigues, Grazielle de Fátima Pinto; Benzi, Jhohann Richard de Lima ; Nardotto, Glauco Henrique Balthazar ; Marques, Maria Paula ; Lanchote, Vera Lucia ; Cavalli, Ricardo de Carvalho
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP
Subjects: TRABALHO DE PARTO INDUZIDO, PROSTAGLANDINAS SINTÉTICAS, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, GRAVIDEZ, HEMORRAGIA, PLACENTA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FILGUEIRA, Gabriela Campos de Oliveira et al. Determination of misoprostol acid in plasma samples by UPLC–MS/MS with application in a maternal-fetal pharmacokinetic study following a low misoprostol dose vaginally to induce labor. Journal of Pharmaceutical and Biomedical Analysis, v. 202, p. 1-7, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2021.114138. Acesso em: 06 nov. 2024.
APA
Filgueira, G. C. de O., Rodrigues, G. de F. P., Benzi, J. R. de L., Nardotto, G. H. B., Marques, M. P., Lanchote, V. L., & Cavalli, R. de C. (2021). Determination of misoprostol acid in plasma samples by UPLC–MS/MS with application in a maternal-fetal pharmacokinetic study following a low misoprostol dose vaginally to induce labor. Journal of Pharmaceutical and Biomedical Analysis, 202, 1-7. doi:10.1016/j.jpba.2021.114138
NLM
Filgueira GC de O, Rodrigues G de FP, Benzi JR de L, Nardotto GHB, Marques MP, Lanchote VL, Cavalli R de C. Determination of misoprostol acid in plasma samples by UPLC–MS/MS with application in a maternal-fetal pharmacokinetic study following a low misoprostol dose vaginally to induce labor [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2021 ; 202 1-7.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.jpba.2021.114138
Vancouver
Filgueira GC de O, Rodrigues G de FP, Benzi JR de L, Nardotto GHB, Marques MP, Lanchote VL, Cavalli R de C. Determination of misoprostol acid in plasma samples by UPLC–MS/MS with application in a maternal-fetal pharmacokinetic study following a low misoprostol dose vaginally to induce labor [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2021 ; 202 1-7.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.jpba.2021.114138
Artigo de periodico
Effects of arginase genetic polymorphisms on nitric oxide formation in healthy pregnancy and in preeclampsia (2021)
Pinto-Souza, Caroline Cristina; Coeli-Lacchini, Fernanda Borchers; Luizon, Marcelo Rizzatti; Cavalli, Ricardo de Carvalho; Lacchini, Riccardo ; Sandrim, Valéria Cristina
Source: Nitric Oxide. Unidades: FMRP, EERP, FCFRP
Subjects: ÓXIDO NÍTRICO, NITRITOS, PRÉ-ECLÂMPSIA, POLIMORFISMO, GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO-SOUZA, Caroline Cristina et al. Effects of arginase genetic polymorphisms on nitric oxide formation in healthy pregnancy and in preeclampsia. Nitric Oxide, v. 109–110, p. 20-25, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.niox.2021.02.003. Acesso em: 06 nov. 2024.
APA
Pinto-Souza, C. C., Coeli-Lacchini, F. B., Luizon, M. R., Cavalli, R. de C., Lacchini, R., & Sandrim, V. C. (2021). Effects of arginase genetic polymorphisms on nitric oxide formation in healthy pregnancy and in preeclampsia. Nitric Oxide, 109–110, 20-25. doi:10.1016/j.niox.2021.02.003
NLM
Pinto-Souza CC, Coeli-Lacchini FB, Luizon MR, Cavalli R de C, Lacchini R, Sandrim VC. Effects of arginase genetic polymorphisms on nitric oxide formation in healthy pregnancy and in preeclampsia [Internet]. Nitric Oxide. 2021 ; 109–110 20-25.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.niox.2021.02.003
Vancouver
Pinto-Souza CC, Coeli-Lacchini FB, Luizon MR, Cavalli R de C, Lacchini R, Sandrim VC. Effects of arginase genetic polymorphisms on nitric oxide formation in healthy pregnancy and in preeclampsia [Internet]. Nitric Oxide. 2021 ; 109–110 20-25.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.niox.2021.02.003
Artigo de periodico
PRENACEL partner - use of short message service (SMS) to encourage male involvement in prenatal care: a cluster randomized trial (2020)
Bonifácio, Lívia Pimenta ; Franzon, Ana Carolina Arruda ; Zaratini, Fabiani Spessoto; Vicentine, Fernanda Bergamini; Barbosa Júnior, Francisco; Braga, Giordana Campos; Sanchez, Jazmin Andrea Cifuentes; Ciabati, Lívia Maria de Oliveira ; Andrade, Magna Santos; Fernandes, Mariana; Fábio, Suzi Volpato; Duarte, Geraldo; Pileggi, Vicky Nogueira; Souza, João Paulo Dias de; Vieira, Elisabeth Meloni
Source: Reproductive Health. Unidades: FMRP, FCFRP, EERP
Subjects: EDUCAÇÃO EM SAÚDE, PROMOÇÃO DA SAÚDE, GRAVIDEZ, DIAGNÓSTICO PRÉ-NATAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFÁCIO, Lívia Pimenta et al. PRENACEL partner - use of short message service (SMS) to encourage male involvement in prenatal care: a cluster randomized trial. Reproductive Health, v. 17, n. 1, 2020Tradução . . Disponível em: https://doi.org/10.1186/s12978-020-0859-6. Acesso em: 06 nov. 2024.
APA
Bonifácio, L. P., Franzon, A. C. A., Zaratini, F. S., Vicentine, F. B., Barbosa Júnior, F., Braga, G. C., et al. (2020). PRENACEL partner - use of short message service (SMS) to encourage male involvement in prenatal care: a cluster randomized trial. Reproductive Health, 17( 1). doi:10.1186/s12978-020-0859-6
NLM
Bonifácio LP, Franzon ACA, Zaratini FS, Vicentine FB, Barbosa Júnior F, Braga GC, Sanchez JAC, Ciabati LM de O, Andrade MS, Fernandes M, Fábio SV, Duarte G, Pileggi VN, Souza JPD de, Vieira EM. PRENACEL partner - use of short message service (SMS) to encourage male involvement in prenatal care: a cluster randomized trial [Internet]. Reproductive Health. 2020 ; 17( 1):[citado 2024 nov. 06 ] Available from: https://doi.org/10.1186/s12978-020-0859-6
Vancouver
Bonifácio LP, Franzon ACA, Zaratini FS, Vicentine FB, Barbosa Júnior F, Braga GC, Sanchez JAC, Ciabati LM de O, Andrade MS, Fernandes M, Fábio SV, Duarte G, Pileggi VN, Souza JPD de, Vieira EM. PRENACEL partner - use of short message service (SMS) to encourage male involvement in prenatal care: a cluster randomized trial [Internet]. Reproductive Health. 2020 ; 17( 1):[citado 2024 nov. 06 ] Available from: https://doi.org/10.1186/s12978-020-0859-6
Artigo de periodico
Interaction between NOS3 and HMOX1 on antihypertensive drug responsiveness in preeclampsia (2020)
Sandrim, Valéria Cristina; Luizon, Marcelo Rizzatti; Pilan, Eliane; Dias, Mayara Caldeira; Coeli-Lacchini, Fernanda Borchers; Kors, Georgia; Berndt, Iuly; Lacchini, Riccardo ; Cavalli, Ricardo de Carvalho
Source: Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics. Unidades: EERP, FMRP, FCFRP
Subjects: PRÉ-ECLÂMPSIA, POLIMORFISMO, ANTIOXIDANTES, ÓXIDO NÍTRICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANDRIM, Valéria Cristina et al. Interaction between NOS3 and HMOX1 on antihypertensive drug responsiveness in preeclampsia. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics, v. 42, n. 8, p. 460-467, 2020Tradução . . Disponível em: https://doi.org/10.1055/s-0040-1712484. Acesso em: 06 nov. 2024.
APA
Sandrim, V. C., Luizon, M. R., Pilan, E., Dias, M. C., Coeli-Lacchini, F. B., Kors, G., et al. (2020). Interaction between NOS3 and HMOX1 on antihypertensive drug responsiveness in preeclampsia. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics, 42( 8), 460-467. doi:10.1055/s-0040-1712484
NLM
Sandrim VC, Luizon MR, Pilan E, Dias MC, Coeli-Lacchini FB, Kors G, Berndt I, Lacchini R, Cavalli R de C. Interaction between NOS3 and HMOX1 on antihypertensive drug responsiveness in preeclampsia [Internet]. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics. 2020 ; 42( 8): 460-467.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1055/s-0040-1712484
Vancouver
Sandrim VC, Luizon MR, Pilan E, Dias MC, Coeli-Lacchini FB, Kors G, Berndt I, Lacchini R, Cavalli R de C. Interaction between NOS3 and HMOX1 on antihypertensive drug responsiveness in preeclampsia [Internet]. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics. 2020 ; 42( 8): 460-467.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1055/s-0040-1712484
Artigo de periodico-carta/editorial
Nonrelevant pharmacokinetic drug-drug interaction between furosemide and pindolol enantiomers in hypertensive parturient women [Carta] (2020)
Gonçalves, Paulo Vinícius Bernardes; Moreira, Fernanda de Lima; Benzi, Jhohann Richard de Lima ; Cavalli, Ricardo de Carvalho; Duarte, Geraldo; Lanchote, Vera Lucia
Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: FARMACOCINÉTICA, TRABALHO DE PARTO INDUZIDO, HIPERTENSÃO NA GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONÇALVES, Paulo Vinícius Bernardes et al. Nonrelevant pharmacokinetic drug-drug interaction between furosemide and pindolol enantiomers in hypertensive parturient women [Carta]. The Journal of Clinical Pharmacology. Hoboken: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/jcph.1719. Acesso em: 06 nov. 2024. , 2020
APA
Gonçalves, P. V. B., Moreira, F. de L., Benzi, J. R. de L., Cavalli, R. de C., Duarte, G., & Lanchote, V. L. (2020). Nonrelevant pharmacokinetic drug-drug interaction between furosemide and pindolol enantiomers in hypertensive parturient women [Carta]. The Journal of Clinical Pharmacology. Hoboken: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/jcph.1719
NLM
Gonçalves PVB, Moreira F de L, Benzi JR de L, Cavalli R de C, Duarte G, Lanchote VL. Nonrelevant pharmacokinetic drug-drug interaction between furosemide and pindolol enantiomers in hypertensive parturient women [Carta] [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 11): 1527-1529.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/jcph.1719
Vancouver
Gonçalves PVB, Moreira F de L, Benzi JR de L, Cavalli R de C, Duarte G, Lanchote VL. Nonrelevant pharmacokinetic drug-drug interaction between furosemide and pindolol enantiomers in hypertensive parturient women [Carta] [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 11): 1527-1529.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/jcph.1719
Artigo de periodico
Direct chiral LC-MS/MS analysis of fexofenadine enantiomers in plasma and urine with application in a maternal-fetal pharmacokinetic study (2020)
Pinto, Leonardo Santos Ribeiro; Vale, Gabriel Tavares do ; Moreira, Fernanda de Lima ; Pereira, Maria Paula Marques ; Coelho, Eduardo Barbosa ; Cavalli, Ricardo de Carvalho ; Lanchote, Vera Lucia
Source: Journal of Chromatography B. Unidades: FCFRP, FMRP, EERP
Subjects: ANTI-HISTAMÍNICOS, FARMACOCINÉTICA, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, PLASMA, GRAVIDEZ, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Leonardo Santos Ribeiro et al. Direct chiral LC-MS/MS analysis of fexofenadine enantiomers in plasma and urine with application in a maternal-fetal pharmacokinetic study. Journal of Chromatography B, v. 1145, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jchromb.2020.122094. Acesso em: 06 nov. 2024.
APA
Pinto, L. S. R., Vale, G. T. do, Moreira, F. de L., Pereira, M. P. M., Coelho, E. B., Cavalli, R. de C., & Lanchote, V. L. (2020). Direct chiral LC-MS/MS analysis of fexofenadine enantiomers in plasma and urine with application in a maternal-fetal pharmacokinetic study. Journal of Chromatography B, 1145. doi:10.1016/j.jchromb.2020.122094
NLM
Pinto LSR, Vale GT do, Moreira F de L, Pereira MPM, Coelho EB, Cavalli R de C, Lanchote VL. Direct chiral LC-MS/MS analysis of fexofenadine enantiomers in plasma and urine with application in a maternal-fetal pharmacokinetic study [Internet]. Journal of Chromatography B. 2020 ; 1145[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.jchromb.2020.122094
Vancouver
Pinto LSR, Vale GT do, Moreira F de L, Pereira MPM, Coelho EB, Cavalli R de C, Lanchote VL. Direct chiral LC-MS/MS analysis of fexofenadine enantiomers in plasma and urine with application in a maternal-fetal pharmacokinetic study [Internet]. Journal of Chromatography B. 2020 ; 1145[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.jchromb.2020.122094
Artigo de periodico
Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio (2020)
Pippa, Leandro Francisco ; Oliveira, Milena Locci de ; Rocha, Adriana; Andrade, Jurandyr Moreira de ; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP
Subjects: ANTINEOPLÁSICOS, FARMACOCINÉTICA, VARIAÇÃO (BIOLOGIA), NEOPLASIAS MAMÁRIAS, MIOCARDIOPATIA CONGESTIVA, QUIMIOTERAPIA, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIPPA, Leandro Francisco et al. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio. Journal of Pharmaceutical and Biomedical Analysis, v. 185, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2020.113231. Acesso em: 06 nov. 2024.
APA
Pippa, L. F., Oliveira, M. L. de, Rocha, A., Andrade, J. M. de, & Lanchote, V. L. (2020). Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio. Journal of Pharmaceutical and Biomedical Analysis, 185. doi:10.1016/j.jpba.2020.113231
NLM
Pippa LF, Oliveira ML de, Rocha A, Andrade JM de, Lanchote VL. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 185[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.jpba.2020.113231
Vancouver
Pippa LF, Oliveira ML de, Rocha A, Andrade JM de, Lanchote VL. Total, renal and hepatic clearances of doxorubicin and formation clearance of doxorubicinol in patients with breast cancer: estimation of doxorubicin hepatic extraction ratio [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 185[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.jpba.2020.113231
Artigo de periodico
A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women (2020)
Benzi, Jhohann Richard de Lima ; Moreira, Fernanda de Lima; Marques, Maria Paula ; Duarte, Geraldo; Suarez-Kurtz, Guilherme; Lanchote, Vera Lucia
Source: Journal of Chromatography B. Unidades: FCFRP, FMRP
Subjects: LÍQUIDOS CORPORAIS, CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, CITOCROMO P-450, INFECÇÕES POR HIV, CORTISOL, ESPECTROMETRIA DE MASSAS, FENÓTIPOS, GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BENZI, Jhohann Richard de Lima et al. A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women. Journal of Chromatography B, v. 1144 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jchromb.2020.122074. Acesso em: 06 nov. 2024.
APA
Benzi, J. R. de L., Moreira, F. de L., Marques, M. P., Duarte, G., Suarez-Kurtz, G., & Lanchote, V. L. (2020). A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women. Journal of Chromatography B, 1144 . doi:10.1016/j.jchromb.2020.122074
NLM
Benzi JR de L, Moreira F de L, Marques MP, Duarte G, Suarez-Kurtz G, Lanchote VL. A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women [Internet]. Journal of Chromatography B. 2020 ; 1144 [citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.jchromb.2020.122074
Vancouver
Benzi JR de L, Moreira F de L, Marques MP, Duarte G, Suarez-Kurtz G, Lanchote VL. A background subtraction approach for determination of endogenous cortisol and 6β-hydroxycortisol in urine by UPLC-MS/MS with application in a within-day variability study in HIV-infected pregnant women [Internet]. Journal of Chromatography B. 2020 ; 1144 [citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.jchromb.2020.122074
Artigo de periodico
Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics (2020)
Pinto, Leonardo Santos Ribeiro; Moreira, Fernanda de Lima ; Nardotto, Glauco Henrique Balthazar ; Cavalli, Ricardo de Carvalho ; Moisés, Elaine Christine Dantas ; Duarte, Geraldo ; Lanchote, Vera Lucia
Source: Pharmaceutical Research. Unidades: FCFRP, FMRP
Subjects: ANTIDEPRESSIVOS, FARMACOCINÉTICA, GRAVIDEZ, ESTUDOS DE CASOS E CONTROLES, MUCOSA INTESTINAL, ANTI-HISTAMÍNICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINTO, Leonardo Santos Ribeiro et al. Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics. Pharmaceutical Research, v. 37, n. 7, 2020Tradução . . Disponível em: https://doi.org/10.1007/s11095-020-02854-4. Acesso em: 06 nov. 2024.
APA
Pinto, L. S. R., Moreira, F. de L., Nardotto, G. H. B., Cavalli, R. de C., Moisés, E. C. D., Duarte, G., & Lanchote, V. L. (2020). Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics. Pharmaceutical Research, 37( 7). doi:10.1007/s11095-020-02854-4
NLM
Pinto LSR, Moreira F de L, Nardotto GHB, Cavalli R de C, Moisés ECD, Duarte G, Lanchote VL. Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics [Internet]. Pharmaceutical Research. 2020 ; 37( 7):[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s11095-020-02854-4
Vancouver
Pinto LSR, Moreira F de L, Nardotto GHB, Cavalli R de C, Moisés ECD, Duarte G, Lanchote VL. Chiral discrimination of p-glycoprotein in parturient women: effect of fluoxetine on maternal-fetal fexofenadine pharmacokinetics [Internet]. Pharmaceutical Research. 2020 ; 37( 7):[citado 2024 nov. 06 ] Available from: https://doi.org/10.1007/s11095-020-02854-4
Artigo de periodico
A pilot study of the maternal-fetal pharmacokinetics of furosemide in plasma, urine, and amniotic fluid of hypertensive parturient women under cesarean section (2020)
Gonçalves, Paulo Vinícius Bernardes; Moreira, Fernanda de Lima; Benzi, Jhohann Richard de Lima ; Duarte, Geraldo; Lanchote, Vera Lucia
Source: The Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: LÍQUIDO AMNIÓTICO, FÁRMACOS DIURÉTICOS, GRAVIDEZ, TRABALHO DE PARTO INDUZIDO, HIPERTENSÃO NA GRAVIDEZ, CESÁREA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONÇALVES, Paulo Vinícius Bernardes et al. A pilot study of the maternal-fetal pharmacokinetics of furosemide in plasma, urine, and amniotic fluid of hypertensive parturient women under cesarean section. The Journal of Clinical Pharmacology, v. 60, n. 12, p. 1655-1661, 2020Tradução . . Disponível em: https://doi.org/10.1002/jcph.1681. Acesso em: 06 nov. 2024.
APA
Gonçalves, P. V. B., Moreira, F. de L., Benzi, J. R. de L., Duarte, G., & Lanchote, V. L. (2020). A pilot study of the maternal-fetal pharmacokinetics of furosemide in plasma, urine, and amniotic fluid of hypertensive parturient women under cesarean section. The Journal of Clinical Pharmacology, 60( 12), 1655-1661. doi:10.1002/jcph.1681
NLM
Gonçalves PVB, Moreira F de L, Benzi JR de L, Duarte G, Lanchote VL. A pilot study of the maternal-fetal pharmacokinetics of furosemide in plasma, urine, and amniotic fluid of hypertensive parturient women under cesarean section [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 12): 1655-1661.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/jcph.1681
Vancouver
Gonçalves PVB, Moreira F de L, Benzi JR de L, Duarte G, Lanchote VL. A pilot study of the maternal-fetal pharmacokinetics of furosemide in plasma, urine, and amniotic fluid of hypertensive parturient women under cesarean section [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 12): 1655-1661.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/jcph.1681
Artigo de periodico
Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study (2020)
Moreira, Fernanda de Lima ; Marques, Maria Paula ; Duarte, Geraldo ; Lanchote, Vera Lucia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FMRP, FCFRP
Subjects: FÁRMACOS, ANTIRRETROVIRAIS, GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Fernanda de Lima et al. Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis, v. 177, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2019.112838. Acesso em: 06 nov. 2024.
APA
Moreira, F. de L., Marques, M. P., Duarte, G., & Lanchote, V. L. (2020). Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis, 177. doi:10.1016/j.jpba.2019.112838
NLM
Moreira F de L, Marques MP, Duarte G, Lanchote VL. Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 177[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.jpba.2019.112838
Vancouver
Moreira F de L, Marques MP, Duarte G, Lanchote VL. Determination of raltegravir and raltegravir glucuronide in human plasma and urine by LC-MS/MS with application in a maternal-fetal pharmacokinetic study [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2020 ; 177[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.jpba.2019.112838
Artigo de periodico
Pharmacokinetics and placental transfer of bupivacaine enantiomers in HIV-infected parturient women on antiretroviral therapy (2020)
Souza, Marília Cristina Oliveira ; Pereira, Maria Paula Marques ; Duarte, Geraldo ; Lanchote, Vera Lucia
Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: ANESTÉSICOS, PARTO, FARMACOCINÉTICA, HIV
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Marília Cristina Oliveira et al. Pharmacokinetics and placental transfer of bupivacaine enantiomers in HIV-infected parturient women on antiretroviral therapy. The Journal of Clinical Pharmacology, v. 60, n. 5, p. 566-572, 2020Tradução . . Disponível em: https://doi.org/10.1002/jcph.1554. Acesso em: 06 nov. 2024.
APA
Souza, M. C. O., Pereira, M. P. M., Duarte, G., & Lanchote, V. L. (2020). Pharmacokinetics and placental transfer of bupivacaine enantiomers in HIV-infected parturient women on antiretroviral therapy. The Journal of Clinical Pharmacology, 60( 5), 566-572. doi:10.1002/jcph.1554
NLM
Souza MCO, Pereira MPM, Duarte G, Lanchote VL. Pharmacokinetics and placental transfer of bupivacaine enantiomers in HIV-infected parturient women on antiretroviral therapy [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 5): 566-572.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/jcph.1554
Vancouver
Souza MCO, Pereira MPM, Duarte G, Lanchote VL. Pharmacokinetics and placental transfer of bupivacaine enantiomers in HIV-infected parturient women on antiretroviral therapy [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 5): 566-572.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/jcph.1554
Artigo de periodico
Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer (2019)
Souza, Marília Cristina Oliveira; Marques, Maria Paula; Duarte, Geraldo; Lanchote, Vera Lúcia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FMRP, FCFRP
Assunto: ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Marília Cristina Oliveira et al. Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer. Journal of Pharmaceutical and Biomedical Analysis, v. 164, p. 268-275, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2018.10.040. Acesso em: 06 nov. 2024.
APA
Souza, M. C. O., Marques, M. P., Duarte, G., & Lanchote, V. L. (2019). Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer. Journal of Pharmaceutical and Biomedical Analysis, 164, 268-275. doi:10.1016/j.jpba.2018.10.040
NLM
Souza MCO, Marques MP, Duarte G, Lanchote VL. Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2019 ; 164 268-275.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.jpba.2018.10.040
Vancouver
Souza MCO, Marques MP, Duarte G, Lanchote VL. Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2019 ; 164 268-275.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.jpba.2018.10.040
Artigo de periodico
Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women (2019)
Carvalho, Daniela Miarelli; Lanchote, Vera Lucia; Filgueira, Gabriela Campos de Oliveira; Nardotto, Glauco Henrique Balthazar; Duarte, Geraldo; Cavalli, Ricardo Carvalho; Moisés, Elaine Christine Dantas
Source: Clinical Pharmacology and Therapeutics. Unidades: FCFRP, FMRP
Subjects: FARMACOCINÉTICA CLÍNICA, PLACENTA, ANTIDEPRESSIVOS, GESTANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Daniela Miarelli et al. Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women. Clinical Pharmacology and Therapeutics, v. 105, n. 4, p. 1003-1008, 2019Tradução . . Disponível em: https://doi.org/10.1002/cpt.1263. Acesso em: 06 nov. 2024.
APA
Carvalho, D. M., Lanchote, V. L., Filgueira, G. C. de O., Nardotto, G. H. B., Duarte, G., Cavalli, R. C., & Moisés, E. C. D. (2019). Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women. Clinical Pharmacology and Therapeutics, 105( 4), 1003-1008. doi:10.1002/cpt.1263
NLM
Carvalho DM, Lanchote VL, Filgueira GC de O, Nardotto GHB, Duarte G, Cavalli RC, Moisés ECD. Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women [Internet]. Clinical Pharmacology and Therapeutics. 2019 ; 105( 4): 1003-1008.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/cpt.1263
Vancouver
Carvalho DM, Lanchote VL, Filgueira GC de O, Nardotto GHB, Duarte G, Cavalli RC, Moisés ECD. Pharmacokinetics and transplacental transfer of fluoxetine enantiomers and their metabolites in pregnant women [Internet]. Clinical Pharmacology and Therapeutics. 2019 ; 105( 4): 1003-1008.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/cpt.1263
Trabalho de evento-anais periodico
Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients (2019)
Ximenez, João Paulo Bianchi ; Andrade, Jurandyr Moreira de ; Marques, Maria Paula ; Coelho, Eduardo Barbosa ; Suarez-Kurtz, Guilherme ; Lanchote, Vera Lucia
Source: BMC Pharmacology and Toxicology. Conference titles: Latin American Congress of Clinical and Laboratorial Toxicology - ToxiLatin. Unidades: FMRP, FCFRP
Subjects: NEOPLASIAS MAMÁRIAS, RECEPTORES DE DROGA, QUIMIOTERAPIA, ESTRÓGENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
XIMENEZ, João Paulo Bianchi et al. Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients. BMC Pharmacology and Toxicology. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s40360-019-0358-y. Acesso em: 06 nov. 2024. , 2019
APA
Ximenez, J. P. B., Andrade, J. M. de, Marques, M. P., Coelho, E. B., Suarez-Kurtz, G., & Lanchote, V. L. (2019). Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients. BMC Pharmacology and Toxicology. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1186/s40360-019-0358-y
NLM
Ximenez JPB, Andrade JM de, Marques MP, Coelho EB, Suarez-Kurtz G, Lanchote VL. Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients [Internet]. BMC Pharmacology and Toxicology. 2019 ; 20 [10] .[citado 2024 nov. 06 ] Available from: https://doi.org/10.1186/s40360-019-0358-y
Vancouver
Ximenez JPB, Andrade JM de, Marques MP, Coelho EB, Suarez-Kurtz G, Lanchote VL. Hormonal status affects plasma exposure of tamoxifen and its main metabolites in tamoxifen-treated breast cancer patients [Internet]. BMC Pharmacology and Toxicology. 2019 ; 20 [10] .[citado 2024 nov. 06 ] Available from: https://doi.org/10.1186/s40360-019-0358-y
Artigo de periodico
ABCG2 c.421C>A polymorphism alters nifedipine transport to breast milk in hypertensive breastfeeding women (2019)
Malfará, Bianca Nayra; Benzi, Jhohann Richard de Lima ; Filgueira, Gabriela Campos de Oliveira ; Zanelli, Cleslei Fernando ; Duarte, Geraldo ; Cavalli, Ricardo de Carvalho ; Moraes, Natália Valadares de
Source: Reproductive Toxicology. Unidades: FMRP, FCFRP
Subjects: NEOPLASIAS MAMÁRIAS, PROTEÍNAS, LEITE MATERNO, HIPERTENSÃO, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALFARÁ, Bianca Nayra et al. ABCG2 c.421C>A polymorphism alters nifedipine transport to breast milk in hypertensive breastfeeding women. Reproductive Toxicology, v. 85, p. 1-5, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.reprotox.2019.01.007. Acesso em: 06 nov. 2024.
APA
Malfará, B. N., Benzi, J. R. de L., Filgueira, G. C. de O., Zanelli, C. F., Duarte, G., Cavalli, R. de C., & Moraes, N. V. de. (2019). ABCG2 c.421C>A polymorphism alters nifedipine transport to breast milk in hypertensive breastfeeding women. Reproductive Toxicology, 85, 1-5. doi:10.1016/j.reprotox.2019.01.007
NLM
Malfará BN, Benzi JR de L, Filgueira GC de O, Zanelli CF, Duarte G, Cavalli R de C, Moraes NV de. ABCG2 c.421C>A polymorphism alters nifedipine transport to breast milk in hypertensive breastfeeding women [Internet]. Reproductive Toxicology. 2019 ; 85 1-5.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.reprotox.2019.01.007
Vancouver
Malfará BN, Benzi JR de L, Filgueira GC de O, Zanelli CF, Duarte G, Cavalli R de C, Moraes NV de. ABCG2 c.421C>A polymorphism alters nifedipine transport to breast milk in hypertensive breastfeeding women [Internet]. Reproductive Toxicology. 2019 ; 85 1-5.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1016/j.reprotox.2019.01.007

USP Schools

ReP

Filtros

Document Types

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation